O2Cure

Company Overview

Snapshot

Founded in May 2013 by Yoram Palti, O2Cure operates with 1–10 employees. The company has raised $6.6M across one funding round from one investor. O2Cure focuses on developing advanced blood oxygenators and respiratory assist devices.

Business overview

O2Cure develops long-term blood oxygenators and respiratory assist devices. The company's core technology utilizes novel carbon nanotube technology and a unique design to enable efficient blood oxygenation with reduced harmful effects on blood in pumpless setups. O2Cure's technology is suitable for use in hospitals, clinics, and home care settings, serving the medical devices and life support sectors within Health Tech & Life Sciences.

Company Intelligence Q&A

What is O2Cure's primary focus?

O2Cure specializes in developing long-term blood oxygenators and respiratory assist devices, utilizing novel carbon nanotube technology for efficient blood oxygenation.

When was O2Cure founded?

O2Cure was founded in May 2013 by Yoram Palti.

What is the status of O2Cure?

O2Cure is currently Non Active, as of January 2022.

What markets does O2Cure target?

O2Cure's technology is designed for use in hospitals, clinics, and home care environments, targeting the healthcare provider segment.

What is the total disclosed funding raised by O2Cure?

O2Cure has raised a total of $6.6M across one funding round. The funding round was a Series B, though the specific date and investor for this disclosed amount are not publicly available.